ERASX
Price
$44.29
Change
-$0.34 (-0.76%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

ERASX vs RPTIX

Header iconERASX vs RPTIX Comparison
Open Charts ERASX vs RPTIXBanner chart's image
Eaton Vance Atlanta Capital SMID-Cap R6
Price$44.29
Change-$0.34 (-0.76%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
ERASX vs RPTIX Comparison Chart
Loading...
VS
ERASX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERASX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. ERASX (15.1B). RPTIX pays higher dividends than ERASX: RPTIX (0.18) vs ERASX (0.15). ERASX was incepted earlier than RPTIX: ERASX (10 years) vs RPTIX (9 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. ERASX (14.00). RPTIX has a lower initial minimum investment than ERASX: RPTIX (500000) vs ERASX (5000000). ERASX annual gain was more profitable for investors over the last year : 24.17 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. ERASX (13.49).
ERASXRPTIXERASX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years9 years-
Gain YTD15.7619.127173%
Front LoadN/AN/A-
Min. Initial Investment50000005000001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets15.1B31.4B48%
Annual Yield % from dividends0.150.1883%
Returns for 1 year24.1714.81163%
Returns for 3 years4.93-13.57-36%
Returns for 5 years13.4915.0989%
Returns for 10 years83.18N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp